Bernhoven Uden

Uden 5406 PT

2 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Crohn's Disease, Dyslipidemia, Ischemic Stroke; Ischemic Attack, Transient, Moderately to Severely Active Crohn Disease, Type2 Diabetes, Ulcerative Colitis

Studies at this site

• Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer — Recruiting now
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• ABTECT - Maintenance — Running, not enrolling
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed